anne burrell glp 1 Burrell's weight loss journey and complete transformation Statement on the Passing of

Only one in five patients on blockbuster weight loss drugs keep the pounds off after stopping the medication, and almost 20 percent regained the weight, a study from Epic Research found.

A subgroup of patients using the GLP-1 tirzepatide experience nearly twice the improvement in sleep apnea severity.

The number of therapeutic options is limited and are often associated with adverse side effects

FDA Concerns Surrounding Compounded GLP-1 In a May 16, 2025 statement, the U.S

Patients were considered to be on treatment for the period during which prescriptions were refilled before the estimated end date of the most recent prescription, including a 90-day grace period, i.e

Ideal for individuals seeking more comprehensive digestive support beyond a basic probiotic